EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Bifidobacterium longum CCFM1077 Attenuates Hyperlipidemia by Modulating the Gut Microbiota Composition and Fecal Metabolites: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial

Chuanqi Chu, Jinchi Jiang, Leilei Yu, Yiwen Li, Songli Zhang, Wei Zhou, Qun Wang, Jianxin Zhao, Qixiao Zhai, Fengwei Tian, Wei Chen

Engineering · 2023-09 · 28 · 193-205

DOI: 10.1016/j.eng.2023.04.010 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Engineering, 2023-09. Verfasst von Chuanqi Chu und 10 weiteren Autor:innen. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Chu, C., Jiang, J., Yu, L., Li, Y., Zhang, S., Zhou, W., Wang, Q., Zhao, J., Zhai, Q., Tian, F., & Chen, W. (2023). Bifidobacterium longum CCFM1077 Attenuates Hyperlipidemia by Modulating the Gut Microbiota Composition and Fecal Metabolites: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Engineering, 28, 193-205. https://doi.org/10.1016/j.eng.2023.04.010

Vancouver

Chu C, Jiang J, Yu L, Li Y, Zhang S, Zhou W, et al. Bifidobacterium longum CCFM1077 Attenuates Hyperlipidemia by Modulating the Gut Microbiota Composition and Fecal Metabolites: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Engineering. 2023;28:193-205. doi:10.1016/j.eng.2023.04.010

BibTeX
@article{Chu2023,
  author = {Chu, Chuanqi and Jiang, Jinchi and Yu, Leilei and Li, Yiwen and Zhang, Songli and Zhou, Wei and Wang, Qun and Zhao, Jianxin and Zhai, Qixiao and Tian, Fengwei and Chen, Wei},
  title = {Bifidobacterium longum CCFM1077 Attenuates Hyperlipidemia by Modulating the Gut Microbiota Composition and Fecal Metabolites: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial},
  journal = {Engineering},
  year = {2023},
  volume = {28},
  pages = {193--205},
  doi = {10.1016/j.eng.2023.04.010}
}
Kostenlos starten →